Ambu Aura GainTM Guided vs Non Guided in Edentulous Ambu Aura GainTM Without Gastric Tube in Endontolous Patient
NCT ID: NCT03933644
Last Updated: 2020-11-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2019-05-15
2020-02-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It has been described and it is known from daily routine, that SGA in edentulous patient provide inferior oropharyngeal leak pressure (OLP).
The aim of the study is to evaluate if the placement of a gastric tube through the second orifice leads to better OLP and lowers the number of intervention needed for replacing the SGA.
The study also evaluates the OLP after 15 minutes and after 30 minutes.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ambu Aura Gain TM with gastric tube
Gastric Tube
SGA is inserted with a gastric tube as guide for insertion
Ambu Aura Gain TM without gastric tube
No gastric Tube
SGA is inserted without a gastric tube as guide for insertion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gastric Tube
SGA is inserted with a gastric tube as guide for insertion
No gastric Tube
SGA is inserted without a gastric tube as guide for insertion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent
* Age 18 - 90 years
* Edentolous (or partial) patients
* Patients scheduled for elective surgery
Exclusion Criteria
* Patients with anatomical disorders in the upper airway, the oesophagus or the trachea
* Patients at risk for aspiration
* Body mass index (BMI) \> 40 kg/m2
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University Innsbruck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lukas Gasteiger, Dr
Role: PRINCIPAL_INVESTIGATOR
Departement for Anaesthesia and Intensive Care - Medical University Innsbruck
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MUInnsbruck
Innsbruck, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zahnlos
Identifier Type: -
Identifier Source: org_study_id